Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy

Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy

  • CN 101,193,632 A
  • Filed: 04/06/2006
  • Published: 06/04/2008
  • Est. Priority Date: 04/08/2005
  • Status: Active Application
First Claim
Patent Images

1. treat method with the nonsense mutation relevant disease, this method comprise with every day three dosage use the 3-[5-(2-fluoro-phenyl)-[1 of effective dose for the patient that these needs are arranged, 2,4] oxadiazole-3-yl]-benzoic acid or its pharmaceutically acceptable salt, solvate or hydrate.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×